150 related articles for article (PubMed ID: 15736433)
21. Expression of the melatonin receptor (MT) 1 in benign and malignant human bone tumors.
Toma CD; Svoboda M; Arrich F; Ekmekcioglu C; Assadian O; Thalhammer T
J Pineal Res; 2007 Sep; 43(2):206-13. PubMed ID: 17645699
[TBL] [Abstract][Full Text] [Related]
22. Pharmacological characterization of human excitatory amino acid transporters EAAT1, EAAT2 and EAAT3 in a fluorescence-based membrane potential assay.
Jensen AA; Bräuner-Osborne H
Biochem Pharmacol; 2004 Jun; 67(11):2115-27. PubMed ID: 15135308
[TBL] [Abstract][Full Text] [Related]
23. Expression and sequences of genes encoding glutamate receptors and transporters in primate retina determined using 3'-end amplification polymerase chain reaction.
Hanna MC; Calkins DJ
Mol Vis; 2006 Aug; 12():961-76. PubMed ID: 16943768
[TBL] [Abstract][Full Text] [Related]
24. Accumulation of [3H] glutamate in cultured rat calvarial osteoblasts.
Takarada T; Hinoi E; Fujimori S; Tsuchihashi Y; Ueshima T; Taniura H; Yoneda Y
Biochem Pharmacol; 2004 Jul; 68(1):177-84. PubMed ID: 15183129
[TBL] [Abstract][Full Text] [Related]
25. Expression of genes encoding glutamate receptors and transporters in rod and cone bipolar cells of the primate retina determined by single-cell polymerase chain reaction.
Hanna MC; Calkins DJ
Mol Vis; 2007 Nov; 13():2194-208. PubMed ID: 18087239
[TBL] [Abstract][Full Text] [Related]
26. Molecular characterization of the cystine/glutamate exchanger and the excitatory amino acid transporters in the rat lens.
Lim J; Lam YC; Kistler J; Donaldson PJ
Invest Ophthalmol Vis Sci; 2005 Aug; 46(8):2869-77. PubMed ID: 16043861
[TBL] [Abstract][Full Text] [Related]
27. Down-regulation of the glial glutamate transporter GLT-1 in rat hippocampus and striatum and its modulation by a group III metabotropic glutamate receptor antagonist following transient global forebrain ischemia.
Chen JC; Hsu-Chou H; Lu JL; Chiang YC; Huang HM; Wang HL; Wu T; Liao JJ; Yeh TS
Neuropharmacology; 2005 Oct; 49(5):703-14. PubMed ID: 16019039
[TBL] [Abstract][Full Text] [Related]
28. Upregulation of mRNAs coding for AMPA and NMDA receptor subunits and metabotropic glutamate receptors in the dorsal horn of the spinal cord in a rat model of diabetes mellitus.
Tomiyama M; Furusawa K; Kamijo M; Kimura T; Matsunaga M; Baba M
Brain Res Mol Brain Res; 2005 May; 136(1-2):275-81. PubMed ID: 15893611
[TBL] [Abstract][Full Text] [Related]
29. Modulation of the glutamatergic receptors (AMPA and NMDA) and of glutamate vesicular transporter 2 in the rat facial nucleus after axotomy.
Eleore L; Vassias I; Vidal PP; de Waele C
Neuroscience; 2005; 136(1):147-60. PubMed ID: 16182453
[TBL] [Abstract][Full Text] [Related]
30. Bone-related growth factors and zoledronic acid regulate the PTHrP/PTH.1 receptor bioregulation systems in MG-63 human osteosarcoma cells.
Tenta R; Sourla A; Lembessis P; Koutsilieris M
Anticancer Res; 2006; 26(1A):283-91. PubMed ID: 16475708
[TBL] [Abstract][Full Text] [Related]
31. Expression of hepatocyte growth factor and the proto-oncogenic receptor c-Met in canine osteosarcoma.
Fieten H; Spee B; Ijzer J; Kik MJ; Penning LC; Kirpensteijn J
Vet Pathol; 2009 Sep; 46(5):869-77. PubMed ID: 19429984
[TBL] [Abstract][Full Text] [Related]
32. Expression of vascular endothelial growth factor-C and its receptor in osteosarcomas.
Park HR; Min K; Kim HS; Jung WW; Park YK
Pathol Res Pract; 2008; 204(8):575-82. PubMed ID: 18440723
[TBL] [Abstract][Full Text] [Related]
33. [Effect of silencing HIF-1alpha by RNA interference on expression of vascular endothelial growth factor in osteosarcoma cell line SaOS-2 under hypoxia].
Wu Q; Yang SH; Wang RY; Ye SN; Xia T; Ma DZ
Ai Zheng; 2005 May; 24(5):531-5. PubMed ID: 15890092
[TBL] [Abstract][Full Text] [Related]
34. Differentiated P19 cells express N-methyl-D-aspartate receptor 1 mRNA binding trans-acting proteins and four N-methyl-D-aspartate receptor 1 splice variants comparable to those in cultured fetal cortical neurons.
Anji A; Kumari M
J Neurosci Res; 2009 May; 87(7):1591-601. PubMed ID: 19156858
[TBL] [Abstract][Full Text] [Related]
35. Syndecan-2 affects the basal and chemotherapy-induced apoptosis in osteosarcoma.
Orosco A; Fromigué O; Bazille C; Entz-Werle N; Levillain P; Marie PJ; Modrowski D
Cancer Res; 2007 Apr; 67(8):3708-15. PubMed ID: 17440083
[TBL] [Abstract][Full Text] [Related]
36. Blockade of glutamate transporters leads to potentiation of NMDA receptor current in layer V pyramidal neurons of the rat prefrontal cortex via group II metabotropic glutamate receptor activation.
Oliveira JF; Krügel U; Köles L; Illes P; Wirkner K
Neuropharmacology; 2008 Sep; 55(4):447-53. PubMed ID: 18680754
[TBL] [Abstract][Full Text] [Related]
37. Estrogen sulfotransferase (SULT1E1) expression in benign and malignant human bone tumors.
Svoboda M; Thalhammer T; Aust S; Arrich F; Assadian O; Toma CD
J Surg Oncol; 2007 Jun; 95(7):572-81. PubMed ID: 17230544
[TBL] [Abstract][Full Text] [Related]
38. RANKL directly induces bone morphogenetic protein-2 expression in RANK-expressing POS-1 osteosarcoma cells.
Wittrant Y; Lamoureux F; Mori K; Riet A; Kamijo A; Heymann D; Redini F
Int J Oncol; 2006 Jan; 28(1):261-9. PubMed ID: 16328004
[TBL] [Abstract][Full Text] [Related]
39. Toxicity of beta-amyloid in HEK293 cells expressing NR1/NR2A or NR1/NR2B N-methyl-D-aspartate receptor subunits.
Domingues A; Almeida S; da Cruz e Silva EF; Oliveira CR; Rego AC
Neurochem Int; 2007 May; 50(6):872-80. PubMed ID: 17403555
[TBL] [Abstract][Full Text] [Related]
40. Fibroblast glutamate transport in aging and in AD: correlations with disease severity.
Zoia CP; Tagliabue E; Isella V; Begni B; Fumagalli L; Brighina L; Appollonio I; Racchi M; Ferrarese C
Neurobiol Aging; 2005 Jun; 26(6):825-32. PubMed ID: 15718040
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
